Skip to main content

Peer Review reports

From: Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

Original Submission
1 Dec 2010 Submitted Original manuscript
22 Jun 2011 Author responded Author comments - Xi-Chun Hu
25 Apr 2011 Reviewed Reviewer Report - Herbert Yu
11 May 2011 Reviewed Reviewer Report - Shiuan Chen
Resubmission - Version 2
22 Jun 2011 Submitted Manuscript version 2
2 Aug 2011 Author responded Author comments - Xi-Chun Hu
13 Jul 2011 Reviewed Reviewer Report - Herbert Yu
Resubmission - Version 3
2 Aug 2011 Submitted Manuscript version 3
6 Sep 2011 Author responded Author comments - Xi-Chun Hu
22 Aug 2011 Reviewed Reviewer Report - Herbert Yu
Resubmission - Version 4
6 Sep 2011 Submitted Manuscript version 4
15 Sep 2011 Author responded Author comments - Xi-Chun Hu
Resubmission - Version 5
15 Sep 2011 Submitted Manuscript version 5
Publishing
22 Sep 2011 Editorially accepted
22 Sep 2011 Article published 10.1186/1471-2407-11-403

You can find further information about peer review here.

Back to article page